Mentor Capital, Inc is a publicly traded private equity firm that invests in and acquires marijuana companies in both the medical and social sectors. The firm primarily provides passive equity to smaller companies and invests in shelf IPOs. Mentor’s major goal is to give public market access to founders and small-business owners.
The company is allowed to raise a total of USD 23 M from the public market. A cannabis company that needs to obtain public market funding may approach Mentor Capital, trading in 10% to 60% of its own business. Mentor Capital, in turn, works on providing higher prices for small slices of business. This is possible due to the firm’s capital structure and investing approach.
Currently, Mentor Capital’s cannabis portfolio comprises a wide array of businesses, namely: Bhang Financial, Bhang Medicinal Chocolate (with agreement in dispute as of October 2014), Brighter Day Health, GW Pharmaceuticals (with the largest index holding), Nevada Cannabis Ventures, MicroCannaBiz, Shaw Capital Management, and Waste Consolidators, Inc.
Though Mentor accommodates both the medical and recreational sectors of the marijuana industry, the firm prefers to focus on the medicine. One of its investments is in fact in cancer immunotherapy sciences. The company however intends to transition completely to the cannabis industry in time.
Mentor Capital has a long history as a company. It was founded in 1985 as a California gym company called Main Street Athletic Clubs. Only in 2008 did it reinvent itself into Mentor Capital, Inc, starting with its cancer sector investments. According to the company, when that sector collapsed, it then moved into the marijuana space.
With a market cap of USD 5.51 M, Mentor Capital is now traded under the symbol MNTR in the OTC markets.
The company is led by CEO, President, and Founder Chester Billingsley; Director James J. Blazeck; and CFO Lori J. Stansfield.
Yahoo! Finance: MNTR News
Latest Financial News for MNTR
SAN DIEGO, CA / ACCESSWIRE / May 16, 2019 / Mentor Capital, Inc. (OTCQX: MNTR) announced that it had filed its quarterly 10-Q filing for the first quarter ended March 31, 2019, with the Securities and Exchange Commission. The Company reports that for the quarter ended March 31, 2019, Mentor had revenues of $1,075,995 and gross profit of $370,374 with a resulting net loss attributable to Mentor of ($2,406,595) or (10.4 cents) per share. This is a revenue increase from the prior year quarter ended March 31, 2018, in which Mentor had revenues of $1,016,199 and gross profit of $345,707 with a resulting net loss attributable to Mentor of ($151,704) or (0.7 cents) per share.
SAN DIEGO, CA / ACCESSWIRE / March 29, 2019 / Mentor Capital, Inc. (MNTR) announced that it had filed its annual 10-K filing for the year December 31, 2018, with the Securities and Exchange Commission. The Company reports that for the year ended December 31, 2018 Mentor had revenues of $5,281,533 and gross profit of $1,582,599 with a resulting net loss attributable to Mentor of ($409,161) or (1.8 cents) per share. The Mentor Capital, Inc. parent company has no non-affiliate debt and collected a net payment of $1,758,949 on January 23, 2018 in satisfaction of the Company's judgment against Bhang Corporation.
SAN DIEGO, CA / ACCESSWIRE / November 14, 2018 / Mentor Capital, Inc. (MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2018, with the Securities and Exchange Commission. For the quarter ended September 30, 2018, Mentor had revenues of $1,031,622 and gross profit of $300,501 with a resulting net income attributable to Mentor of $77,224 or 0.3 cents per share. This is an improvement over the prior year quarter ended September 30, 2017 revenues of $815,102 and gross profit of $289,211, with a resulting net loss attributable to Mentor of ($285,796) or (1.3 cents) per share.
SAN DIEGO, CA / ACCESSWIRE / October 1, 2018 / Mentor Capital, Inc. (OTCQX: MNTR) announced today that it has been invited to present and answer investor questions at the OTCQX® Virtual Investor Conference ...
Mentor Capital, Inc. (MNTR) announced that its investment in G FarmaLabs Limited has increased to $2,700,000 following yesterday’s seventh investment tranche delivered to G Farma of $250,000 from Mentor for additional leased equipment and working capital. Nicole Gonzalez, Founder of G FarmaBrands, comments, “With financial backing from Mentor Capital, G FarmaLabs has hit its benchmarks on the way to building cannabis efficient facilities and production lines.” Ata Gonzalez, Co-Founder of G FarmaLabs concludes, “Chet provides both money and a wealth of knowledge. “Mentor Capital focuses new investment from shareholders and other investors on larger cannabis companies, like G Farma, that have the potential to go public and who may be incubated by Mentor along that path,” explained Mentor Capital, Inc. CEO, Chet Billingsley.